Información del producto
Ledipasvir D-tartrate is a synthetic, broad-spectrum antiviral agent that is used to treat hepatitis C virus (HCV) infection. It inhibits the HCV NS5A protein, which is needed for viral replication and assembly. Ledipasvir D-tartrate was discovered by scientists at Gilead Sciences. The drug was approved for use in combination with sofosbuvir in 2017 as an oral treatment for chronic HCV infection.
Ledipasvir D-tartrate binds to the NS5A protein and blocks its ability to function, thereby inhibiting viral replication. Ledipasvir D-tartrate also prevents the production of new viruses by blocking the activity of other proteins needed for viral assembly and release from infected cells.
It is effective against a wide variety of microorganisms, including bacteria, fungi, and parasites. It has been shown to be active against methicillin-resistant Staphylococ
Propiedades químicas
Consulta técnica sobre: 3D-FL180961 Ledipasvir D-tartrate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
